Stockreport

Is Esperion Therapeutics's (NASDAQ:ESPR) Share Price Gain Of 215% Well Earned? [Yahoo! Finance News]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Is Esperion Therapeutics's (NASDAQ:ESPR) Share Price Gain Of 215% Well Earned? The most you can lose on any stock assuming you don't use leverage) is 100% of your money. [Read more]